Brand Owner-CMO Collaboration Is Growing--But Is Far From Mature
The long-recommended practice of shared data and plans between biopharma companies and their contract manufacturing organizations (CMOs) is beginning to take hold . . .
Recalls Stimulate Scrutiny of Quality Assurance in Drug Packaging
Maintaining product quality and meeting regulatory specifications is a daily challenge for pharma manufacturers, but recent events have shown that the quality requirements do not end as pills or vials come off the production line- they must be extended , , ,
Patient-Administered Therapies Drive New Delivery System Designs
Historically, one of the barriers for patient acceptance of injectable drugs is a simple but practically unavoidable one: fear of needles. Today, however, the increasing shift from inpatient hospital care to outpatient services . . .
Industry Grapples With the Growing Complexity of Contract Manufacturing Supply Chains
While all the market indicators point to healthy growth, managing the CMO relationship is a challenge. Industry collaboration might fill in the regulatory gap . . .
